Mutation of p53 gene in hepatocellular carcinoma cell lines with HBX DNA

International Journal of Cancer

Volumn 67, Issue 6, 1996, Pages 898-902

  Kang, Myung Soo ^a   Lee, Hong Joo ^a   Lee, Jae Ho ^a   Ku, Ja Lok ^a   Lee, Kathreen P ^a   Kelley, Michael J ^b   Won, Yong Jin ^a   Kim, Soo Tae ^a   Park, Jae Gahb ^a  

^a Seoul National University   (South Korea)

^b NATIONAL NAVAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; PROTEIN P53; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; GENE MUTATION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; TUMOR CELL LINE;

CARCINOMA, HEPATOCELLULAR; DNA, VIRAL; GENES, P53; HUMANS; LIVER NEOPLASMS; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED;

EID: 0029910021     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960917)67:6<898::AID-IJC22>3.0.CO;2-X     Document Type: Article

References (36)

1. BRESSAC, B., GALVIN, K.M., LIANG, T.G., ISSELBACHER, K.J., WANDS, J. and OZTURK, M., Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. Proc. nat. Acad. Sci. (Wash.), 87, 1973-1977 (1990).
2. BRESSAC, B., KEW, M., WANDS, J. and OZTURK, M., Selective G to T mutations of p53 gene in hepatocellular carcinoma from south Africa. Nature (Lond.), 350, 429-431 (1991).
3. CHO, Y., GORINA, S., JEFFREY, P.D. and PALVETICH, N.P., Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science, 265, 346-355 (1994).
4. DI BISCEGLIE, A.M., RUSTGI, V.K., HOOFNAGLE, J.H., DUSHEIKO, G.M. and LOTZE, M.T., Hepalocellular carcinoma. Ann. int. Med., 108, 390-401 (1988).
5. DIAMANTIS, I.D., MCGANDY, C.E., CHEN, T.J., LIAG, Y.F., GUDAT, F. and BIANCHI, L., Hepatitis B × gene expression in hepatocellular carcinoma. J. Hepatol., 15, 400-403 (1992).
6. FEITELSON, M.A., ZHU, M., DUAN, L.X. and LONDON, W.T., Hepatitis B × antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene, 8, 1109-1117 (1993).
7. FOGH, J., FOGH, J.M. and ORFEO, T., One hundred and twenty-seven cultured human-tumor cell lines producing tumors in nude mouse. J nat. Cancer Inst., 59, 221-225 (1977).
8. GANEM, D., VARMUS, H.E., The molecular biology of the hepatitis B viruses. Ann. Rev. Biochem., 56, 651-693 (1987).
9. GREENBLATT, M.S., BENNETT, W.D., HOLLSTEIN, M. and HARRIS, C.C., Mutations in the p53 tumor suppressor gene: Clues to etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878 (1994).
10. HENKLER, F., WASEEN, N., GOLDING, M.H.C., ALISON, M.R. and KOSHY, R., Mutant p53 but not hepatitis B virus X protein is present in hepatitis B virus-related human hepatocellular carcinoma. Cancer Res., 55, 6084-6091 (1995).
11. HOLLSTEIN, M., RICE, C., GREENBLATT, M.S., SOUSSI, T., FUCHS, T. and SORLIE, E., Database of p53 somatic mutations in human tumors and tumor cell lines, European Molecular Biology Laboratory, Heidelberg (1995).
12. HOLLSTEIN, M., SIDRANSKY, D., VOGELSTEIN, B. and HARRIS, C.C., p53 mutations in human cancer. Science, 253, 49-53 (1991).
13. HSU, I.C., METCALF, R.A., SUN, T., WELSH, J.A., WANG, N.J. and HARRIS, C.C., Mutational hotspot in the p53 gene in the human hepatocellular carcinoma. Nature (Lond.), 350, 427-428 (1991).
14. HSU, I.C., TOKIWA, T., BENNETT, W., METCALF, R.A., WELSCH, J.A, SUN, T. and HARRIS, C.C., p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines. Carcinogenesis 14, 987-992 (1993).
15. KAWAJIRI, K., NAKACHI, K., IMAI, K., WATANABE, J. and HAYASHI, S., Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer. Carcinogenesis, 14, 1085-1089 (1993).
16. KIM, C.M., KOIKE, K., SAITO, I., MIYAMURA, T. and JAY, G., HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature (Lond.), 351, 317-320 (1991).
17. KNOWLES, B., HOWE, C.C. and ADEN, D.P., Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science 209, 497-499 (1980).
18. LAMB, P. and CRAWFORD, L., Characterization of the human p53 gene. Mol. Cell Biol., 6, 1379-1385 (1986).
19. MITSUDOMI, T., STEINBERG, S.M., NAU, M.M., CARBONE, D., D'AMICO, D., BONDER, S., OIE, H.K., LINNOILA, R., MULSHINE, J., MINNA, J.D. and GAZDAR, A.F., p53 gene mutations in non small cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene, 7, 171-180 (1992).
20. MORIARTY, A.M., ALEXANDER, H. and LERNER, R.A., Antibodies to peptides detect new hepatitis B antigen: Serological correlation with hepatocellular carcinoma. Science, 227, 429-433 (1985).
21. MURAKAMI, Y., HAYASHI, K., HIROHASHI, S. and SEKIYA, T., Aberrations of the tumor suppressor p53 and retinoblastoma gene in human hepatocellular carcinomas. Cancer Res., 51, 520-5525 (1991a).
22. MURAKAMI, Y., HAYASHI, K. and SEKIYA, T., Detection of the p53 alleles and the gene transcript in human tumor cell lines by single strand conformation polymorphism analysis, Cancer Res., 51, 3356-3361 (1991b).
23. NISHIDA, N., FUKUDA, Y., KOKURYU, H., TOGUCHIDA, J., YANDELL, D.W., IKENEGA, M., IMAMURA, H. and ISHIZAKI, K., Role and mutational heterogeneity of the c53 gene in hepatocellular carcinoma, Cancer Res., 53, 368-372 (1993).
24. ORITA, M., IWAHANA, H., KANAZAWA, H., HAYASHI, K. and SEKIYA, T., Detection of polymorphisms of human DNA by gel electrophoresis as single strand conformation polymorphisms. Proc. nat. Natl Acad. Sci. (Wash.), 86, 2766-2770 (1989).
25. OZTURK, M. and 26 OTHERS: p53 mutation in hepatocellular carcinoma after aflatoxin exposure, Lancet 338, 1356-1359 (1991).
26. PARK, J.G., LEE, S.K., HONG, I.K., KIM, H.S., CHOE, K.J., KIM, W.H., KIM, Y.I., TSURUO, T. and GOTTESMAN, M.M., MDR1 gene expression: Its effects on drug resistance to doxorubicin in human hepatocellular carcinoma cell lines. J. nat. Cancer Inst., 86, 700-705 (1994).
27. PARK, J.G. and 17 OTHERS, Characterization of cell lines established from human hepalocellular carcinoma. Int. J. Cancer, 62, 276-282 (1995).
28. SAMBROOK, J., FRITSCH, E.F., MANIATIS, T., Molecular cloning: a laboratory manual, (2nd ed.) Cold Spring Harbor Laboratory Press, NY (1989).
29. SAMESHIMA, Y., MATSUNO, Y., HIROHASHI, S., SHIMOSATO, Y., MIZOGUCHI, H., SUGIMURA, T., TEREDA, M. and YOKOTA, J., Alteration of p53 gene are common and critical events for the maintenance of malignant phenotypes in small cell lung cancer. Oncogene, 7, 451-457 (1992).
30. SHIN, H.R., HBV or HCV infection and risk of HCC in Korea. Proceeding of the Federation Meeting of Korean Basic Medical Scientist, p. 86 (1993).
31. SHIRAKATA, Y., KAWADA, M., FUJIKI, Y., SANO, H., ODA, M., YAGINUMA, K., KOBAYASHI, M., and KOIKE, K., The × gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH3T3 cells. Jpn. J. Cancer Res., 80, 617-621 (1898).
32. TRUANT, R., ANTUNOVIC, J., GREENBLATT, J., PRIVES, C., and CROMLISH, J.A., Direct interaction of the hepatitis B virus HBX protein with p53 leads to inhibition by HBX of p53 response element directed transaction. J. Virol., 69, 1851-1859 (1995).
33. UNSAL, H., YAKICIER, C., MARCAIS, C., KEW, M., VOLKMANN, M., ZENTGRAFT, H., ISSELBACHER, K.J. and OZTURK, M., Genetic heterogeneity of hepatocellular carcinoma. Proc. nat. Acad. Sci. (Wash.), 91, 822-826 (1994).
34. WANG, X.W., FORRESTER, K., YEH, H., FEITELSON, M.K., GU, J.-R. and HARRIS, C.C., Hepatitis B virus × protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc. nat. Acad. Sci. (Wash.), 91, 2230-2234 (1994).
35. WESTON, A., LING-CAWLEY, H.M., CAPORASO, N.B., BOWMAN, E.D., HOOVER, R.N., TRUMP, B.F. and HARRIS, C.C., Determination of the allelic frequencies of an L-myc and a p53 polymorphism in human lung cancer. Carcinogenesis, 15, 583-587 (1994).
36. WESTON, A., PERRIN, L.S., FORRESTOR, K., HOOVER, R.N., TRUMP, B.F., HARRIS, C.C. and CAPORASO, N.E., Allelic frequency of a p53 polymorphism in human lung cancer. Cancer Epidemiol. Biomarkers Prev., 1, 481-483(1992).